FOLFOX regimen Clinical Trials
9 recruitingDrug
Phase 28Phase 11
Showing 1–9 of 9 trials
Recruiting
Phase 2
Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer
Locally Advanced Colorectal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences170 enrolled3 locationsNCT06154538
Recruiting
Phase 2
Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma
Metastatic Gastric AdenocarcinomaAdvanced Esophageal AdenocarcinomaAdvanced Gastric Adenocarcinoma+1 more
UNICANCER88 enrolled4 locationsNCT06846346
Recruiting
Phase 2
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
Biliary Tract Cancer
UNICANCER72 enrolled3 locationsNCT06529718
Recruiting
Phase 2
First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer
Gastric Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group120 enrolled37 locationsNCT06253611
Recruiting
Phase 2
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
Rectal Cancer
Weill Medical College of Cornell University43 enrolled3 locationsNCT05024097
Recruiting
Phase 1
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
Advanced Solid Tumors
Providence Health & Services110 enrolled1 locationNCT06719362
Recruiting
Phase 2
Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)
Colorectal Carcinoma
Neil Kopek35 enrolled1 locationNCT06991465
Recruiting
Phase 2
Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme
Digestive Cancer
UNICANCER400 enrolled34 locationsNCT06475352
Recruiting
Phase 2
Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer
Gastroesophageal Junction AdenocarcinomaGastric AdenocarcinomaEsophagus Adenocarcinoma
UNICANCER118 enrolled29 locationsNCT05476796